Partner With Us
Build and validate the future of longitudinal disease decision support. BioTraject Systems collaborates with clinical, health-system, research, data, technology, life-sciences, and strategic partners to develop and evaluate responsible computational decision systems for chronic disease. Our current focus is NephroSync™, a computational decision system in development for chronic kidney disease.
Why partner with BioTraject
Meaningful healthcare technology cannot be built in isolation. Clinical relevance, data quality, workflow fit, validation, implementation, and governance all require collaboration. BioTraject is seeking partners who can help define important questions, test the technology in real-world settings, and shape responsible pathways toward use.
Four ways to work together
BioTraject works with partners across four areas: clinical and health systems; research and evidence; data and technology; and life sciences and strategy. Full detail is below.
How collaboration works
- Define the question — clarify the clinical, scientific, operational, or development objective.
- Assess fit — review the available data, population, workflow, resources, and intended use.
- Design the engagement — agree on scope, methods, responsibilities, safeguards, milestones, and success criteria.
- Evaluate and learn — conduct the study, pilot, or development work and interpret findings within the agreed boundaries.
- Determine next steps — decide whether additional validation, refinement, implementation planning, or a broader collaboration is appropriate.
Partnership areas
Four ways to work together with BioTraject Systems.
Clinical and health systems
Retrospective validation, prospective pilots, clinical workflow design, care-pathway evaluation, and implementation planning.
Research and evidence
Longitudinal disease research, trajectory analysis, outcome forecasting, real-world evidence, and clinical-study design.
Data and technology
Health-data integration, interoperability, secure infrastructure, user-interface development, and workflow deployment.
Life sciences and strategy
Disease-progression research, patient stratification, treatment-response analysis, evidence generation, and responsible commercialization.
Current opportunities
Starting with chronic kidney disease. BioTraject is currently prioritizing collaborations that can advance the development and evaluation of NephroSync™ — including CKD cohort studies, model validation, clinical plausibility review, workflow design, pilot preparation, data integration, and real-world evidence generation.
Future disease-specific collaborations will be considered selectively and will require their own clinical grounding, data, development plan, validation, safeguards, and intended-use definition.
What we value
Partnerships grounded in a clear purpose.
- A meaningful clinical, scientific, or operational question
- Fit-for-purpose longitudinal data or a realistic pathway to obtain it
- Clinical and domain leadership
- Transparent expectations and clearly defined responsibilities
- Commitment to rigorous evaluation, appropriate safeguards, and responsible communication
Tell us what you are working on.
Use the partnership form to share your organization, area of interest, and the problem you would like to explore. Please do not submit protected health information, confidential patient data, proprietary source code, or other sensitive material through the form.
